Pro Dex (PDEX) Net Income towards Common Stockholders (2010 - 2026)

Pro Dex (PDEX) reported Net Income towards Common Stockholders of $3.9 million for Q1 2026, up 20.24% on a YoY basis from $3.3 million in Q1 2025, and up 80.06% sequentially from $2.2 million in Q4 2025.

Pro Dex (PDEX) Net Income towards Common Stockholders (2010 - 2026) Analysis & Trends

Pro Dex (PDEX) has 14 years of Net Income towards Common Stockholders data on file, last reported at $3.9 million in Q1 2026.

  • For the quarter ending Q1 2026, Net Income towards Common Stockholders rose 20.24% year-over-year to $3.9 million; the trailing twelve-month figure through Mar 2026 stood at $12.0 million (up 28.12% YoY), and the FY2025 full-year result was $9.0 million, up 322.1% from the prior year.
  • Net Income towards Common Stockholders climbed to $3.9 million in Q1 2026, from $2.2 million in the prior quarter.
  • In the past five years, Net Income towards Common Stockholders ranged from a high of $4.7 million in Q3 2025 to a low of -$615000.0 in Q3 2023.
  • A 5-year average of $1.9 million and a median of $2.0 million in 2024 frame the typical range for Net Income towards Common Stockholders.
  • Across the five-year window, Net Income towards Common Stockholders plunged 151.12% in 2023 and surged 500.98% in 2024, its largest moves.
  • Tracing PDEX's Net Income towards Common Stockholders over 5 years: stood at $2.8 million in 2022, then plunged by 81.83% to $500000.0 in 2023, then jumped by 308.0% to $2.0 million in 2024, then climbed by 7.21% to $2.2 million in 2025, then soared by 80.06% to $3.9 million in 2026.
  • Business Quant data shows PDEX's Net Income towards Common Stockholders at $3.9 million in Q1 2026, $2.2 million in Q4 2025, and $4.7 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Income (Qtr)
1 Intuitive Surgical 126.02 Bn 120.80 Bn 1.96 Bn 823.20 Mn
2 Becton Dickinson 44.98 Bn 44.16 Bn 2.15 Bn -274.00 Mn
3 Alcon 33.07 Bn 31.41 Bn 1.53 Bn 22.13 Bn
4 Medline 33.03 Bn 30.80 Bn 1.84 Bn 239.00 Mn
5 Resmed 29.47 Bn 27.81 Bn 890.98 Mn 398.73 Mn
6 West Pharmaceutical Services 23.28 Bn 22.84 Bn 329.20 Mn 147.90 Mn
7 Solventum 14.06 Bn 13.50 Bn 1.10 Bn 13.00 Mn
8 Cooper Companies 13.93 Bn 13.79 Bn 735.40 Mn -77.90 Mn
9 Align Technology 12.10 Bn 11.04 Bn 736.59 Mn 112.77 Mn
10 Pro Dex 180.53 Mn 171.48 Mn 6.13 Mn 3.94 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 3.94 Mn
Dec 31, 2025 2.19 Mn
Sep 30, 2025 4.68 Mn
Jun 30, 2025 1.20 Mn
Mar 31, 2025 3.28 Mn
Dec 31, 2024 2.04 Mn
Sep 30, 2024 2.47 Mn
Jun 30, 2024 1.59 Mn
Mar 31, 2024 655,000.00
Dec 31, 2023 500,000.00
Sep 30, 2023 -615,000.00
Jun 30, 2023 2.11 Mn
Mar 31, 2023 1.62 Mn
Dec 31, 2022 2.75 Mn
Sep 30, 2022 1.20 Mn
Jun 30, 2022 2.51 Mn
Mar 31, 2022 462,000.00
Dec 31, 2021 925,000.00
Sep 30, 2021 1.37 Mn
Jun 30, 2021 1.10 Mn